Clinical Trials Browser

Phase 2/3 × OTHER × Sirolimus × Clear all

NCT07366801 2026-01-26

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Phase 2/3 Recruiting

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04987463 2024-02-08

ViRap

Phase 2/3 Recruiting

Epilepsy, Neoplasms, Tuberous Sclerosis

NCT03047980 2021-11-01

Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome

Phase 2/3 Completed

10 enrolled 11 charts

Sturge-Weber Syndrome, Cognitive Dysfunction

NCT00922129 2014-01-14

Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer

Phase 2/3 Withdrawn

Prostatic Neoplasms

NCT00328770 2013-06-24

De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Phase 2/3 Completed

70 enrolled 9 charts

Gastrointestinal

Carcinoma, Hepatocellular